Pulmonx (LUNG) Cash from Operations (2019 - 2025)

Pulmonx (LUNG) has 7 years of Cash from Operations data on file, last reported at 8200000.0 in Q3 2025.

• On a quarterly basis, Cash from Operations fell 13.89% year-over-year to 8200000.0 in Q3 2025; TTM through Sep 2025 was 32037000.0, a 3.65% increase from a year earlier, with the FY2024 full-year figure at 31537000.0, up 16.15% from the prior year.
• Cash from Operations for Q3 2025 stood at 8200000.0, down from 3900000.0 in the prior quarter.
• Over the last five years, Cash from Operations for LUNG reached as high as 3900000.0 in Q2 2025 and fell as low as 15000000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 9522000.0 across 5 years, with a median of 9600000.0 in 2022.
• Across the five-year window, Cash from Operations tumbled 64.04% in 2021 and surged 32.76% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 10688000.0 in 2021, then advanced by 8.25% to 9806000.0 in 2022, then gained by 13.84% to 8449000.0 in 2023, then climbed by 20.26% to 6737000.0 in 2024, then dropped by 21.72% to 8200000.0 in 2025.
• Per Business Quant data, the three most recent Cash from Operations figures were 8200000.0 in Q3 2025, 3900000.0 in Q2 2025, and 13200000.0 in Q1 2025.